| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | insulin glargine (Toujeo®) |
| Formulation | subcutaneous injection |
| Reference number | 4044 |
| Indication | Treatment of diabetes mellitus in adolescents and children from the age of 6 years |
| Company | Sanofi |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 12/02/2020 |